JMD Bill & Melinda Gates Foundation
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Originally published online as doi:10.2353/jmoldx.2009.090064 on September 18, 2009

Published online before print September 18, 2009
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Material
Right arrow All Versions of this Article:
jmoldx.2009.090064v1
11/6/524    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Pasmant, E.
Right arrow Articles by Vidaud, D.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pasmant, E.
Right arrow Articles by Vidaud, D.
Journal of Molecular Diagnostics 2009, Vol. 11, No. 6
Copyright © 2009 American Society for Investigative Pathology & Association for Molecular Pathology
DOI: 10.2353/jmoldx.2009.090064

Technical Advances

Detection and Characterization of NF1 Microdeletions by Custom High Resolution Array CGH

Eric Pasmant*{dagger}, Audrey Sabbagh*{dagger}, Julien Masliah-Planchon{dagger}, Véronique Haddad{dagger}, Marie-José Hamel{dagger}, Ingrid Laurendeau*, Jean Soulier{ddagger}, Béatrice Parfait*{dagger}, Pierre Wolkenstein§, Ivan Bièche*{dagger}, Michel Vidaud*{dagger} and Dominique Vidaud*{dagger}

From the INSERM UMR745, * Université Paris Descartes, Faculté des Sciences Pharmaceutiques et Biologiques, Paris; the Service de Biochimie et de Génétique Moléculaire, {dagger} Hôpital Beaujon, Clichy; the INSERM UMR728, {ddagger} Unité d’Immuno-Hématologie and Laboratoire d’Hématologie, Hôpital Saint-Louis, Paris; and the Service de Dermatologie, § Hôpital Henri Mondor, Créteil, France

In 5% to 10% of cases, neurofibromatosis type 1 is caused by microdeletions scattered across the entire NF1 gene and various neighboring genes. The phenotype appears to be more severe in patients with NF1 microdeletions than in patients with NF1 single point mutations. We have developed a new method for detecting and characterizing NF1 microdeletions based on a custom high-resolution oligonucleotide array comparative genomic hybridization by using the custom 8x15K Agilent array format. The array comprised a total of 14,207 oligonucleotide probes spanning the whole of chromosome 17, including 12,314 probes spanning an ~8 Mb interval surrounding the NF1 locus. We validated this approach by testing NF1 microdeleted DNA samples previously characterized by means of microsatellites and real-time PCR methods. Our array comparative genomic hybridization provided enough information for subsequent long-range PCR and nucleotide sequencing of the microdeletion endpoints. Unlike previously described methods, our array comparative genomic hybridization was able to unambiguously differentiate between the three types of microdeletions (type I, type II, and atypical) and to characterize atypical microdeletions. Further comparative studies of patients with well-characterized genotypes and phenotypes and different microdeletions sizes and breakpoints will help determine whether haploinsufficiency of deleted genes and/or genes rearrangements influence clinical outcomes.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by the American Society for Investigative Pathology and the Association for Molecular Pathology.